Isolated limb infusion with cytotoxic agents: a simplified approach for venous access

Cancer

Volumn 116, Issue 2, 2010, Pages 459-464

  Vyas, Ajit ^a   Avritscher, Rony ^a   Ensor, Joe ^a   Ross, Merrick ^a   Wallace, Michael J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Deep venous thrombosis; Isolated limb infusion; Isolated limb perfusion; Lymphoma; Melanoma; Regional therapy

Indexed keywords

CYTOTOXIC AGENT; ENOXAPARIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FLUOROSCOPY; HUMAN; INTERMETHOD COMPARISON; ISOLATED LIMB INFUSION; MAJOR CLINICAL STUDY; MALE; MELANOMA; OPERATING ROOM; PATIENT SAFETY; POPLITEAL VEIN; PRIORITY JOURNAL; VASCULAR ACCESS; VEIN CATHETERIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETERIZATION; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; VEINS; VENOUS THROMBOSIS;

EID: 75649125293     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24736     Document Type: Article

References (21)

1. Elhassadi E, Egan E, O'Sullivan G, Mohamed R. Isolated limb infusion with cytotoxic agent for treatment of localized refractory cutaneous T-cell lymphoma. Clin Lab Haematol. 2006;28:279-281.
2. Moncrieff MD, Kroon HM, Kam PC, Stalley PD, Scolyer RA, Thompson JF. Isolated limb infusion for advanced soft tissue sarcoma of the extremity. Ann Surg Oncol. 2008; 15:2749-2756.
3. Hegazy MA, Kotb SZ, Sakr H, et al. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas. Ann Surg Oncol. 2007;14:568-576.
4. Damian DL, Barnetson RS, Rose BR, Bonenkamp JJ, Thompson JF. Treatment of refractory hand warts by isolated limb infusion with melphalan and actinomycin D. Australas J Dermatol. 2001;42:106-109.
5. Thompson JF, et al. Isolated limb infusion with melphalan for recurrent limb melanoma: a simple alternative to isolated limb infusion. Reg Cancer Treat. 1994;7:188-192.
6. Thompson JF, Kam PC. Isolated limb infusion for melanoma: a simple but effective alternative to isolated limb perfusion. J Surg Oncol. 2004;88:1-3.
7. Brady MS, Brown K, Patel A, Fisher C, Marx W. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity. Ann Surg Oncol. 2006;13:1123-1129.
8. Roberts MS, Wu ZY, Siebert GA, Anissimov YG, Thompson JF, Smithers BM. Pharmacokinetics and pharmacodynamics of melphalan in isolated limb infusion for recurrent localized limb malignancy. Melanoma Res. 2001;11:423-431.
9. Siemann DW, M.Chapman, A.Beikirch. Effects of oxygenation and pH on tumor cell response to alkylating chemotherapy. Int J Radiat Oncol Biol Phys. 1991;20:287-289.
10. Skarsgard LD, Skwarchuk MW, Vinczan A, Kristl J, Chaplin DJ. The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake. Anticancer Res. 1995;15:219-223.
11. Beasley GM, Petersen RP, Yoo J, et al. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Ann Surg Oncol. 2008;15:2195-2205.
12. Thompson JF, Kam PC, Waugh RC, Harman CR. Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol. 1998;14:238-247.
13. Lindner P, Doubrovsky A, Kam PC, Thompson JF. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma. Ann Surg Oncol. 2002;9:127-136.
14. Lens MB, Dawes M. Isolated limb perfusion with melphalan in the treatment of malignant melanoma of the extremities: a systematic review of randomised controlled trials. Lancet Oncol. 2003;4:359-364.
15. Mian R, Henderson MA, Speakman D, Finkelde D, Ainslie J, McKenzie A. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion. Can J Surg. 2001;44:189-192.
16. Social Security Death Index Interactive Search. Available at: http://ssdi.rootsweb.ancestry.com. Accessed December 2008.
17. Kroon HM, Moncrieff M, Kam PC, Thompson JF. Outcomes following isolated limb infusion for melanoma. A 14-year experience. Ann Surg Oncol. 2008;15:3003-3013.
18. Labropoulos N, Waggoner T, Sammis W, Samali S, Pappas PJ. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms. J Vasc Surg. 2008;48:407-412.
19. Cassumbhoy R, Pitman AG. Isolated limb infusion for local control of lower limb melanoma: radiologic aspects. Australas Radiol. 2007;51:543-549.
20. Augustine CK, Yoshimoto Y, Gupta M, et al. Targeting Ncadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res. 2008;68:3777-3784.
21. Yoshimoto Y, Augustine CK, Yoo JS, et al. Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents. Mol Cancer Ther. 2007;6: 1492-1500.